Clinical Trials

New Search
Title   A Long-Term, Open-Label Follow-up Study of Tofacitinib for Treatment of Juvenile Idiopathic Arthritis (JIA)
Disease/Condition   Rheumatic Diseases,Pediatrics,Arthritis,Musculoskeletal Diseases,Autoimmune Diseases
Eligibility Criteria   Click here for eligibility requirements
Principal Investigator   Dawn Wahezi, MD
Contact Name   Marija Dionizovik-Dimanovski, MD
Contact Email   mdionizo@montefiore.org
IRB/Protocol Number   15-10-199-01
Status   Active/Enrolling
Adult Clinical Trial   No
Pediatric Clinical Trial   Yes
Sub-Specialty   Rheumatology